G
Gad Getz
Researcher at Broad Institute
Publications - 627
Citations - 309042
Gad Getz is an academic researcher from Broad Institute. The author has contributed to research in topics: Cancer & Biology. The author has an hindex of 189, co-authored 520 publications receiving 247560 citations. Previous affiliations of Gad Getz include University of Colorado Denver & University of California, San Diego.
Papers
More filters
Journal ArticleDOI
Lack of transgenerational effects of ionizing radiation exposure from the Chernobyl accident
Meredith Yeager,Mitchell J. Machiela,Prachi Kothiyal,Michael Dean,Clara Bodelon,Shalabh Suman,Mingyi Wang,Lisa Mirabello,Chase W. Nelson,Chase W. Nelson,Weiyin Zhou,Cameron D. Palmer,Bari J. Ballew,Leandro M. Colli,Neal D. Freedman,Casey L. Dagnall,Amy Hutchinson,Vibha Vij,Yosi Maruvka,Yosi Maruvka,Maureen Hatch,Iryna Illienko,Yuri Belayev,Nori Nakamura,Vadim V. Chumak,Elena Bakhanova,David Belyi,Victor Kryuchkov,Ivan Golovanov,Natalia Gudzenko,Elizabeth K. Cahoon,Paul S. Albert,Vladimir Drozdovitch,Mark P. Little,Kiyohiko Mabuchi,Chip Stewart,Gad Getz,Dimitry Bazyka,Amy Berrington de Gonzalez,Stephen J. Chanock +39 more
TL;DR: In this paper, the effects of radiation exposure from the Chernobyl nuclear accident were investigated in children born to parents employed as cleanup workers or exposed to occupational and environmental ionizing radiation after the accident.
Journal ArticleDOI
Passenger Hotspot Mutations in Cancer.
Julian M. Hess,Andre Bernards,Jaegil Kim,Mendy Miller,Amaro Taylor-Weiner,Nicholas J. Haradhvala,Michael S. Lawrence,Gad Getz +7 more
TL;DR: It is shown that many cancer hotspot mutations recurring at the same genomic site across multiple tumors are actually passenger events, recurring at inherently mutable genomic sites under no positive selection.
Journal ArticleDOI
Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non-Muscle-Invasive Bladder Cancer.
Joaquim Bellmunt,Jaegil Kim,Brendan Reardon,Brendan Reardon,Júlia Perera-Bel,Anna Orsola,Alejo Rodriguez-Vida,Stephanie A. Wankowicz,Stephanie A. Wankowicz,Michaela Bowden,Justine A. Barletta,Juan Morote,Inés de Torres,Nuria Juanpere,Josep Lloreta-Trull,Silvia Hernández,Kent W. Mouw,Mary-Ellen Taplin,Paloma Cejas,Henry W. Long,Eliezer M. Van Allen,Eliezer M. Van Allen,Gad Getz,Gad Getz,David J. Kwiatkowski,David J. Kwiatkowski +25 more
TL;DR: It is suggested that management of HGT1 bladder cancer may be improved via molecular characterization to predict outcome via high mutational burden, ERCC2 mutations, and high APOBEC-A/ERCC2 mutation signatures were associated with good outcome.
Posted ContentDOI
FireCloud, a scalable cloud-based platform for collaborative genome analysis: Strategies for reducing and controlling costs
Chet Birger,Megan Hanna,Salinas E,Neff J,Gordon Saksena,Dimitri Livitz,Daniel Rosebrock,Chip Stewart,Ignaty Leshchiner,Alexander Baumann,Douglas Voet,Kristian Cibulskis,Eric Banks,Anthony A. Philippakis,Gad Getz +14 more
TL;DR: In this paper, the authors present guidelines for optimizing workflows to minimize cost and reduce latency in a collaborative genome analysis platform built on a cloud computing infrastructure, including dynamic disk sizing to efficiently utilize virtual disks, tuned provisioning of virtual machines (VMs) using a performance monitoring tool, and utilizing the optimal parallelization of a task9s workload.
Journal ArticleDOI
Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer.
Sahar Nissim,Ignaty Leshchiner,Ignaty Leshchiner,Joseph D. Mancias,Matthew B. Greenblatt,Ophélia Maertens,Christopher A. Cassa,Jill A. Rosenfeld,Andrew G. Cox,Andrew G. Cox,John Hedgepeth,Julia Wucherpfennig,Andrew J. Kim,Jake Henderson,Patrick Gonyo,Anthony Brandt,Ellen L. Lorimer,Bethany Unger,Jeremy W. Prokop,Jerry R. Heidel,Xiaoxu Wang,Chinedu Ukaegbu,Benjamin C. Jennings,Joao A. Paulo,Sebastian Gableske,Carol A. Fierke,Gad Getz,Gad Getz,Shamil R. Sunyaev,Shamil R. Sunyaev,J. Wade Harper,Karen Cichowski,Karen Cichowski,Alec C. Kimmelman,Yariv Houvras,Sapna Syngal,Sapna Syngal,Carol L. Williams,Wolfram Goessling +38 more
TL;DR: Zebrafish modeling and biochemical approaches suggest that truncated RABL3 elevates KRAS activity via accelerated prenylation and uncover a mechanism for dysregulated RAS activity in development and cancer.